Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Other Accumulated Expenses (2011 - 2013)

Cryo Cell International (CCEL) reported Other Accumulated Expenses of $900000.0 for Q4 2013, little changed year-over-year from $900000.0 in Q4 2012, and little changed on a QoQ basis from $900000.0 in Q4 2012.

Cryo Cell International (CCEL) has 3 years of Other Accumulated Expenses data on file, last reported at $900000.0 in Q4 2013.

  • Quarterly Other Accumulated Expenses changed 0.0% year-over-year to $900000.0 in Q4 2013, while the trailing twelve-month figure through Nov 2013 was $900000.0 (changed 0.0% YoY) and the FY2013 annual result came in at $900000.0, changed 0.0% from the prior year.
  • Other Accumulated Expenses held at $900000.0 in Q4 2013 per CCEL's latest filing, from $900000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $900000.0 in Q4 2011 and bottomed at $900000.0 in Q4 2011.
  • The 3-year median for Other Accumulated Expenses is $900000.0 (2011), against an average of $900000.0.
  • Peak annual rise in Other Accumulated Expenses reached 0.0% in 2012, while the deepest fall reached 0.0% in 2012.
  • Tracing CCEL's Other Accumulated Expenses over 3 years: stood at $900000.0 in 2011, then changed by 0.0% to $900000.0 in 2012, then changed by 0.0% to $900000.0 in 2013.
  • Per Business Quant, the three latest CCEL Other Accumulated Expenses figures stand at $900000.0 (Q4 2013), $900000.0 (Q4 2012), and $900000.0 (Q4 2011).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Cryo Cell International 27.15 Mn 24.25 Mn 6.03 Mn

Historic Data

Download Data 🔒
DateValue
Nov 30, 2013 900,000.00
Nov 30, 2012 900,000.00
Nov 30, 2011 900,000.00